Metastatic brain tumors after esophagus surgery study
Part of Brain & nervous system, Cancer, Digestive system clinical trials.
This study looks at people who had esophageal cancer surgery and later developed brain metastases. It may help doctors better understand who benefits from treatment planning after the original cancer surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had surgery for esophageal cancer between January 1, 2000 and December 31, 2019
- Your surgery was either after chemotherapy/radiation (before surgery), or a main surgery, or a “salvage” surgery to treat remaining cancer
- Your esophageal cancer was adenocarcinoma or squamous cell carcinoma (the usual two cancer types)
- Your cancer was not an earlier, very limited stage (cT IS-1a, no lymph nodes, no spread)
- Your surgery was not done only to relieve symptoms (not a palliative surgery)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies stomach and esophageal cancers that spread to the brain. It compares the genetic makeup of the original tumor to the brain metastasis, which may help find better treatments.
This study looks back at past patients’ medical and pathology records from esophageal cancer surgeries. It may help improve how doctors understand which advanced tumors should be treated, by reviewing outcomes in specific tumor stages.
This trial studies whether adding chemotherapy after surgery for esophageal squamous cell cancer can reduce the chance the cancer returns. It focuses on people whose surgery removed cancerous lymph nodes and who are healthy enough to tolerate chemotherapy.
This study looks at whether giving radiation after surgery (after chemo and radiation before surgery) can improve outcomes for people with squamous cell esophagus cancer in the chest. You may be considered if you are well enough for treatment and your cancer has not spread.
This Phase 3 trial looks at the best next step after surgery for thoracic esophageal squamous cell cancer that has spread to nearby lymph nodes. It compares adding chemotherapy, adding chemoradiation (chemotherapy plus radiation), or not adding additional treatment right away, to see which approach works best and is safest.
This study is looking for people newly diagnosed with esophageal cancer or cancer at the stomach-esophagus junction who are planning to have surgery. The goal is to see if certain noninvasive tests (like scans) can help predict how the disease will progress.
Hear when a new Esophageal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.